LENZ

Lenz Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 4/10
Lenz Therapeutics sales and earnings growth
LENZ Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -111.63%
  • FCF Y/Y↓ -67.89%
Lenz Therapeutics gross and profit margin trends
LENZ Profitability
Neutral
  • Gross margin ↑ 92.90%
  • EPS margin↓ -519.30%
  • ROIC 5Y↓ -52.34%
Lenz Therapeutics net debt vs free cash flow
LENZ Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Lenz Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks